Michael focuses his practice primarily on transactional matters, representing both private equity and strategic investors in a range of transactions, including public and private mergers and acquisitions, public company divestitures, leveraged buyouts, joint ventures, minority investments and cross-border transactions.
Prior to joining Ropes & Gray, Michael was a mergers & acquisitions associate in the New York office of an international law firm. Prior to practicing law in the U.S., Michael worked as a mergers & acquisitions associate in the Beijing office of Fangda Partners, a leading Chinese law firm, where he focused primarily on representing U.S. and other international clients in their transactions in China. Michael passed the PRC Bar Exam.
- Represented China National Chemical Corporation in connection with its $43 billion acquisition of Syngenta AG (NYSE: SYT; SIX: SYNN) by way of concurrent public tender offers in Switzerland and the U.S. *
- Represented Pamplona Capital Management in connection with its $2.7 billion acquisition of MedAssets, Inc. (NASDAQ: MDAS) and the divestiture of the Spend and Clinical Resource Management business segment of MedAssets to VHA-UHC Alliance. *
- Represented NXP Semiconductors N.V. (NASDAQ: NXPI) in connection with its $40 billion cash and stock acquisition of Freescale Semiconductor, Ltd. (NYSE: FSL). *
- Represented Pamplona Capital Management in connection with its sale of a controlling stake in Alvogen, a privately owned pharmaceutical company, to a consortium of investors led by CVC Capital Partners and Temasek. *
- Represented Stonepeak Infrastructure Partners in connection with its minority investment in Vertical Bridge, a private owner and manager of wireless communication infrastructure. *
- Represented Emerson Electric Co. (NYSE: EMR) in connection with its sale of a majority interest in its Embedded Computing & Power business to Platinum Equity. *
- Represented TPG, KKR, GIC and The Great Eastern Life Assurance in connection with their joint acquisition of Morgan Stanley’s 34.3% equity interests in China International Capital Corporation (CICC), China’s leading investment bank. *
* Prior to joining Ropes & Gray